| Acute Kidney Injury Research | Lifetime | 15 | DE 1 | 99.68 |
| Cell Adhesion Molecules Research | Lifetime | 116 | DE 7 | 99.50 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 273 | DE 6 | 99.33 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 55 | DE 5 | 99.31 |
| Sepsis Diagnosis and Treatment | Lifetime | 141 | DE 8 | 99.26 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 56 | DE 3 | 99.11 |
| Immune Response and Inflammation | Lifetime | 347 | DE 24 | 99.10 |
| Cardiac Arrest and Resuscitation | Lifetime | 405 | DE 16 | 98.83 |
| Anesthesia and Neurotoxicity Research | Lifetime | 254 | DE 16 | 98.18 |
| Cardiac Ischemia and Reperfusion | Lifetime | 249 | DE 19 | 98.25 |
| Muscle and Compartmental Disorders | Lifetime | 80 | DE 2 | 98.13 |
| S100 Proteins and Annexins | Lifetime | 185 | DE 16 | 97.83 |
| Hemodynamic Monitoring and Therapy | Lifetime | 331 | DE 15 | 98.00 |
| Platelet Disorders and Treatments | Lifetime | 330 | DE 20 | 97.99 |
| Chronic Kidney Disease and Diabetes | Lifetime | 330 | DE 20 | 98.13 |
| Chemokine receptors and signaling | Lifetime | 206 | DE 15 | 96.75 |
| Blood disorders and treatments | Lifetime | 906 | DE 70 | 91.77 |
| Poisoning and overdose treatments | Lifetime | 699 | DE 26 | 90.89 |
| GDF15 and Related Biomarkers | Lifetime | 690 | DE 48 | 78.28 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 4 | DE 1 | 99.76 |
| Acute Kidney Injury Research | 2021-2025 | 3 | DE 1 | 99.84 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 6 | DE 3 | 98.01 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 31 | DE 2 | 99.32 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 18 | DE 2 | 99.00 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 9 | DE 2 | 99.00 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 112 | DE 8 | 98.57 |
| S100 Proteins and Annexins | 2021-2025 | 19 | DE 3 | 95.58 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 147 | DE 11 | 96.21 |
| Muscle and Compartmental Disorders | 2021-2025 | 27 | DE 1 | 94.20 |
| Immune Response and Inflammation | 2021-2025 | 361 | DE 18 | 85.78 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 143 | DE 18 | 86.48 |
| Cell Adhesion Molecules Research | 2021-2025 | 407 | DE 48 | 79.36 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 469 | DE 31 | 67.25 |
| Electrolyte and hormonal disorders | 2021-2025 | 995 | DE 49 | 58.56 |
| Poisoning and overdose treatments | 2021-2025 | 798 | DE 12 | 54.68 |
